You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Nature this week: combining genome-wide association and transcriptome study data homes in on cells involved in brain disorders, and more.
Researchers combined genome-wide association and transcriptome study data to uncover cell types affected by complex brain disorders, including Parkinson's disease.
The institute will use Curetis' Unyvero Hospitalized Pneumonia panel on high-risk patients admitted to the ICU for COVID-19 pneumonia.
The Solna, Sweden-based company is currently expanding from offering in situ sequencing services to selling kits.
In PLOS this week: loci linked to vitamin D metabolism, rapid diagnostic for Chagas disease, and more.
In Science this week: discussions of definition of 'human' and expression profiles of blood cells.
Investigators analyzed the expression of protein-coding genes in 18 blood immune cell populations, comparing the expression profiles with those in other cell and tissue types.
Led by investigators at the University of Oslo, the four-year CoMorMent project is slated to commence next month with a total budget of €6 million.
CUTseq uses enzyme-based fragmentation and in vitro transcription to barcode DNA, saving money when preparing 1,000 samples or more.
The incubator, housed on the campus of the Karolinska Institute, draws upon the experience of its partners in genomics, diagnostics, business development, and corporate law.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.